Fig. 3From: Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertensionWeight loss in patients treated with GLP-1-RAs and controls. **p < 0.01, ***p < 0.001Back to article page